Suchergebnisse - "Osonoi, Takeshi"

PubPharm (151)

1

Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes : A subgroup analysis of the SURPASS J-mono study

enthalten in: Diabetes, obesity & metabolism | 2024

von Osonoi, T. | Oura, T. | Hirase, T.

2

Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes

enthalten in: Diabetologia | 2023

von Mita, T. | Katakami, N. | Okada, Y. | +12

3

Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes

enthalten in: Diabetologia | 2023

von Mita, T. | Katakami, N. | Okada, Y. | +12

4

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes : an extension of the SPEAD-A study

enthalten in: Scientific reports | 2023

von Mita, T. | Katakami, N. | Yoshii, H. | +13

5

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin

enthalten in: The New England journal of medicine | 2023

von Rosenstock, J. | Bain, S. | Gowda, A. | +107

CommentIn: Ann Intern Med. 2023 Oct;176(10):JC113. - PMID 37782932

6

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease : a 2-year extension study of the UTOPIA trial

enthalten in: Cardiovascular diabetology | 2023

von Katakami, N. | Mita, T. | Yoshii, H. | +81

7

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

enthalten in: Cardiovascular diabetology | 2023

von Katakami, N. | Mita, T. | Yoshii, H. | +23

8

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

enthalten in: Cardiovascular diabetology | 2023

von Katakami, N. | Mita, T. | Yoshii, H. | +23

9

Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy : Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

enthalten in: Diabetes, obesity & metabolism | 2023

von Rossing, P. | Garweg, J. | Anker, S. | +10

10

Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia

enthalten in: Diabetes, metabolic syndrome and obesity : targets and therapy | 2023

von Osonoi, T. | Shirabe, S. | Saito, M. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]